Literature DB >> 711325

Cross-protection in mice after immunization with H2N2, H3N2, and Heq2Neq2 influenza virus strains.

W J Anker, A K Bakker, N Masurel.   

Abstract

Mice were vaccinated with the influenza viruses A/Japan/57 (H2N2), A/Hong Kong/68 (H3N2), and A/Equi/Miami/63 (Heq2Neq2) and the hemagglutinin and neuraminidase recombinants derived from these viruses. After infection with the parent viruses, protection was compared with serological findings. It was found that influenza vaccine protects not only against infection with a strain identical or closely related to the vaccine strain, but against heterologous strains as well. Vaccination with Hong Kong/68 and its neuraminidase recombinant resulted in a heterologous neuraminidase inhibition titer against Japan/57 and in a protection against infection with Japan/57. By contrast, after vaccination with Japan/57 and its neuraminidase recombinant, no relevant heterologous neuraminidase inhibition titer against Hong Kong/68 was observed, whereas a protection against infection with Hong Kong/68 did exist. A cross-protection between Hong Kong/68 and Miami/63, but no relationship in the hemagglutination or neuraminidase inhibition tests, was established in the preinfection sera. A one-way antigenic relationship between these viruses was confirmed by the rise of hemagglutinin or neuraminidase antibodies against Hong Kong/68 in the postinfection sera. No cross-protection or serological relationship existed between Miami/63 and Japan/57. Besides the hemagglutinin and neuraminidase, a third factor, the "mouse-protecting antigen," was considered to contribute to the protection obtained. According to the protection observed, the mouse-protecting antigen of Hong Kong/68 virus is related to that of Japan/57 as well as Miami/63 virus. The mouse-protecting antigens of both Japan/57 and Miami/63 are related to that of Hong Kong/68.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 711325      PMCID: PMC421962          DOI: 10.1128/iai.21.1.96-101.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses.

Authors:  H J Zweerink; S A Courtneidge; J J Skehel; M J Crumpton; B A Askonas
Journal:  Nature       Date:  1977-05-26       Impact factor: 49.962

2.  [Local and general immune responses in rabbits after intratracheal administration of influenza virus (author's transl)].

Authors:  M M Riottot; M Thibon; J Pillot
Journal:  Ann Microbiol (Paris)       Date:  1977 May-Jun

3.  Immune responses to influenza virus in rabbits after local immunization. i.--Local and systemic humoral response.

Authors:  K Kasturi; C Hannoun
Journal:  Ann Microbiol (Paris)       Date:  1977-01

4.  Antigenic relationship of influenza-virus neuraminidases from Asian, Hong Kong, and Equi-2 strains.

Authors:  A J Baars; H Frankena; N Masurel
Journal:  Antonie Van Leeuwenhoek       Date:  1971       Impact factor: 2.271

5.  The significance of influenza virus neuraminidase in immunity.

Authors:  R Rott; H Becht; M Orlich
Journal:  J Gen Virol       Date:  1974-01       Impact factor: 3.891

6.  The genes of influenza virus.

Authors:  P Palese
Journal:  Cell       Date:  1977-01       Impact factor: 41.582

7.  Immunological and physicochemical studies of influenza matrix (M) polypeptides.

Authors:  J S Oxford; G C Schild
Journal:  Virology       Date:  1976-10-15       Impact factor: 3.616

8.  Antigenic profile of neuraminidases of influenza A viruses isolated in 1957-1973.

Authors:  T Y Luzyanina; D B Golubev; N A Ivanova; E B Grinbaum; M N Aptekareva; V V Vaitkiene; N B Rumel
Journal:  Acta Virol       Date:  1974-11       Impact factor: 1.162

9.  Functional significance of sialidose during influenza virus multiplication.

Authors:  J T Seto; R Rott
Journal:  Virology       Date:  1966-12       Impact factor: 3.616

10.  Natural infection with influenza A (H3N2). The development, persistance and effect of antibodies to the surface antigens.

Authors:  A J Smith; J R Davies
Journal:  J Hyg (Lond)       Date:  1976-10
View more
  4 in total

1.  Cellular and humoral immune responses to pandemic influenza vaccine in healthy and in highly active antiretroviral therapy-treated HIV patients.

Authors:  Chiara Agrati; Cristiana Gioia; Concetta Castilletti; Daniele Lapa; Giulia Berno; Vincenzo Puro; Fabrizio Carletti; Eleonora Cimini; Carla Nisii; Flora Castellino; Federico Martini; Maria R Capobianchi
Journal:  AIDS Res Hum Retroviruses       Date:  2012-05-08       Impact factor: 2.205

2.  Killer T cell responses to influenza A during a drift period: studies in mice.

Authors:  D Armerding; H Rossiter; E Liehl
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

Review 3.  Cellular immunity and memory to respiratory virus infections.

Authors:  D L Woodland; R J Hogan; W Zhong
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

4.  A miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigens.

Authors:  Matthew R Sandbulte; Jin Gao; Timothy M Straight; Maryna C Eichelberger
Journal:  Influenza Other Respir Viruses       Date:  2009-09       Impact factor: 4.380

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.